IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I1A14

First-in-man transfemoral transcatheter aortic valve implantation with the ACURATE neo for the treatment of aortic regurgitation

Stefan Toggweiler1, MD; Patric Biaggi2, MD; Jürg Grünenfelder2, MD; Ivan Reho2, MD; Ines Bühler2; Roberto Corti2*, MD

An 82-year-old man with multiple comorbidities had severe symptomatic aortic regurgitation due to degeneration of the leaflets and prolapse of the right coronary cusp (Moving image 1). Computed tomography revealed an annulus of 22×28 mm (mean 25 mm) without relevant calcification. We hypothesised that an ACURATE neo™, L (Symetis SA, Ecublens, Switzerland) transcatheter heart valve (THV) might provide enough oversizing to anchor the valve securely within the annulus, despite the absence of calcification. Bail-out open heart surgery was discussed with the patient in case of procedural failure.

To improve visualisation during transcatheter aortic valve implantation, positioning and deployment of the THV was performed under rapid pacing (Panel A, Panel B, Moving image 2- Moving image 4). Within the first minutes after implantation, the valve migrated a few millimetres towards the left ventricle, until it had reached a stable position with the upper crown sitting just above the native valve leaflets (Panel C, the initial position after release, Panel D, the final position). Since the amount of migration was very limited, there was still sufficient sealing with the native annulus (Moving image 5, Moving image 6). In this case, the upper crown of the ACURATE neo (L), the outer diameter of which is about 32 mm, was crucial to anchor the valve and prevent it from further migration into the left ventricle. In conclusion, the Symetis ACURATE neo transfemoral THV may be well suited for the treatment of uncalcified, pure aortic regurgitation, as long as there is the option for sufficient oversizing.

Conflict of interest statement

S. Toggweiler is a proctor for Symetis. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Baseline echocardiography of the aortic regurgitation.

Moving image 2. Initial positioning of the ACURATE neo under semi-rapid pacing.

Moving image 3. Positioning after deployment of the upper crown under rapid pacing.

Moving image 4. Full deployment of the valve prosthesis under rapid pacing.

Moving image 5. Final angiogram.

Moving image 6. Transthoracic echocardiography at one-month follow-up.

Supplementary data

To read the full content of this article, please download the PDF.

Baseline echocardiography of the aortic regurgitation.

Initial positioning of the ACURATE neo under semi-rapid pacing.

Positioning after deployment of the upper crown under rapid pacing.

Full deployment of the valve prosthesis under rapid pacing.

Final angiogram.

Transthoracic echocardiography at one-month follow-up.

Volume 12 Number 1
May 16, 2016
Volume 12 Number 1
View full issue


Key metrics

Suggested by Cory

Research correspondence

10.4244/EIJ-D-22-00740 Apr 24, 2023
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis
Vanhaverbeke M et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00826 Sep 18, 2020
ACURATE neo valve perforation after valve-in-valve transcatheter aortic valve implantation
Rück A et al
free

Editorial

10.4244/EIJ-E-23-00058 Jan 1, 2024
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial
Windecker S and Tomii D
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved